MSD, known as Merck & Co., Inc in the United States and Canada, is a global biopharmaceutical company and a leading investor in the UK, with four sites in the UK and a significant commitment to build a new, state of the art discovery research centre and HQ in central London. For nearly 100 years, we have been researching, developing, and supplying new medicines and vaccines in the UK that prevent and treat diseases that occur at every stage of life.
At MSD, we want to improve lung cancer care across the UK and believe that the first step is to highlight the significant burden lung cancer has on our communities. That is why we are working to raise awareness of lung cancer and the needs of patients across the UK.
August 23rd 2023